Continuing Education Courses

Continuing Education (CE) courses are 3.5 hours each and are held either Sunday morning (8:00 am–11:30 am), Sunday afternoon (1:00 pm–4:30 pm), or the full day (8:00 am–4:30 pm). Preregistration is required, and seating is limited. Times listed are in Mountain Standard Time.

With the exception of the full day Study Director/Monitor course, CE AM and PM course registrants may switch to a different AM and PM course without paying an additional course registration fee until November 5. After November 5, switching courses will be regarded as a separate registration, and an additional course fee will be required. Due to the variance in course registration fees, switching from the Study Director/Monitor course to a different CE course is not permitted.

The following learning levels have been identified for ACT educational offerings.

Below are the titles of the Continuing Education courses to be presented at this year’s Annual Meeting. Detailed information about each CE course will be shared in April.

• Assessing Suitable Transgenic/Humanized Mouse (huMouse) Models and Their Utility for Nonclinical Safety Evaluation—Case Study Examples
• Do It Right: How to Interact with Global Regulatory Affairs on the Way to the Clinic and Through Marketing Approval
• Fundamentals of Artificial Intelligence/Machine Learning in Toxicology and Regulatory Decision Making
• Growing Up in the ICH S11 Era: Advanced Topics in Juvenile Animal Toxicology
• Minipigs in Toxicology: Where Are We Now and What Does the Future Hold?
• Neurotoxicology Case Studies: An Interactive Session Involving Industry and Regulatory Perspectives on Pharmaceutical Development
• Strategies for Successful Nonclinical Studies: Study Director and Study Monitor Workshop
• The Discovery of MicroRNAs and the Evolution of Small RNA-Based Therapeutics
• When, What, and How Developmental and Reproductive Toxicity Data Impact Clinical Trials and Labeling